Skip to main content

Press Releases Tagged with pay for delay

Statement by FTC Chairman Jon Leibowitz Regarding Today’s District Court Decision Denying a Motion to Dismiss the Commission’s Pay-For-Delay Case Against Cephalon Inc. (March 29, 2010 )
Statement by FTC Chairman Jon Leibowitz Regarding Continuing Need for Legislation Banning Illegal Pay-for-Delay Drug Settlements (March 18, 2010 )
Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending Pay-for-Delay Drug Settlements, Praises Inclusion in Presidents Health Care Proposal (February 22, 2010 )
FTC Chairman, Members of Congress Call for Legislation to End Sweetheart Pay-for-Delay Deals That Keep Generic Drugs Off the Market (January 13, 2010 )
Statement of FTC Chairman Jon Leibowitz Regarding the Senate Judiciary Committee's Passage of the Preserve Access to Affordable Generics Act (S. 369) (October 15, 2009 )
Statement by FTC Chairman Jon Leibowitz on Adoption of the Pay for Delay Amendment to the Americas Affordable Health Choices Act of 2009 by the House Energy and Commerce Committee (July 31, 2009 )
FTC Chairman Leibowitz: Eliminating Pay-for-Delay Pharmaceutical Settlements Would Save Consumers $3.5 Billion Annually (June 23, 2009 )
FTC Testifies in Support of Bill Banning Pay-for-Delay Settlements Between Brand and Generic Drug Companies (June 3, 2009 )
FTC Testifies in Support of Bill Banning Pay-for-Delay Settlements Between Brand and Generic Drug Companies (March 31, 2009 )
FTC Sues Drug Companies for Unlawfully Conspiring to Delay the Sale of Generic AndroGel Until 2015 (February 2, 2009 )
FTC Testifies Before U.S. Senate on Barriers to Entry of Generic Drugs (May 2, 2007 )
FTC Provides Senate Testimony on Anticompetitive Patent Settlements in the U.S. Pharmaceutical Industry (January 17, 2007 )
FTC Requests Re-Hearing in Schering-Plough Case (April 22, 2005 )